March 1, 2017 Bio/Pharma/CRO Product Launch

GE Healthcare expands MRI contrast media product range in Europe with launch of macrocyclic agent Clariscan

VIENNA, AUSTRIA – 1 March, 2017 – Growing its range of magnetic resonance imaging (MRI) contrast media options available to patients and radiologists, GE Healthcare today announced the launch of Clariscan™ (gadoteric acid) at the European Congress of Radiology (ECR) 2017 meeting. Clariscan is a gadolinium-based contrast agent (GBCA) designed to support effective visualisation of... Read more

February 7, 2017 Bio/Pharma/CRO M&A, Partnerships

Austrian Centre of Industrial Biotechnology and GE Healthcare establish a cell line engineering collaboration

CHALFONT ST. GILES, UK and GRAZ/WIEN, AUSTRIA – 7 February 2017 –  The Austrian Centre of Industrial Biotechnology (acib) and GE Healthcare are introducing a cell line engineering research collaboration to bring increased productivity to biomanufacturers. The goal of the three-year partnership is to explore and identify new tools and methods to modify and optimize... Read more

February 2, 2017 Bio/Pharma/CRO M&A, Partnerships

Arven Pharmaceuticals selects GE Healthcare’s FlexFactory to improve Turkish and regional access to biopharmaceuticals

CHALFONT ST. GILES, UK and ISTANBUL, TURKEY– 2 February 2017 – Arven Pharmaceuticals, a Toksoz Group Company, has selected GE Healthcare’s FlexFactory manufacturing platform to expand production capacity at its facility in Kirklareli, Turkey. With this expanded capacity, Arven will support local healthcare needs by bringing biopharmaceuticals to the Turkish and surrounding markets faster, whilst... Read more

January 11, 2017 Clinical Research/Diagn. Product Launch

Extending Ultrasound’s Impact: GE Healthcare’s New Vscan Extend Empowers Clinicians in Critical Moments

London – 11 January 2017 – Bringing ultrasound care into every setting in any environment  around the globe1, GE Healthcare today unveiled its new generation of pocket-sized, dual-probe ultrasound, the Vscan Extend™2. From the hospital and ambulance to more rural environments1, Vscan Extend™ uses incredible image quality and wireless connectivity3  to help users increase clinical... Read more

January 3, 2017 Licensing, IP, and Legal

GE Healthcare to commercialize Rapiscan® outside the US, Canada & Mexico for increased access to heart exams

CHALFONT ST. GILES, UK – 3 January, 2017 – GE Healthcare’s Life Sciences business announced today that it has acquired Rapidscan Pharma Solutions Inc., which has the exclusive rights to produce and sell the pharmacological stress agent Rapiscan® (regadenoson) in territories outside the USA, Canada and Mexico. GE Healthcare’s strong industry presence and existing customer and... Read more

November 28, 2016 Clinical Research/Diagn. M&A, Partnerships

Boston Children’s Hospital and GE Healthcare Working Together to Create Smart Imaging Technology to Better Detect Pediatric Brain Disorders

Chicago, Illinois – November 28, 2016 – Boston Children’s Hospital and GE Healthcare today announced a collaboration to develop and commercialize digital solutions to advance the diagnosis and treatment of specific childhood diseases – starting with diseases that affect the brain. The first project, detailed today at the 102nd annual meeting of the Radiological Society... Read more

November 28, 2016 PR/Corporate Product Launch

GE Healthcare showcases industry-first technologies and digital solutions, focused on improving outcomes, at RSNA 2016

CHICAGO – November 27, 2016 – GE Healthcare is launching 25 new products, services and digital solutions at RSNA 2016, 50 percent more than in 2015, as the company focuses on helping the healthcare industry to improve outcomes. The new innovations and partnerships are designed to address some of the industry’s most pressing challenges and... Read more

November 27, 2016 Licensing, IP, and Legal PR/Corporate

GE Healthcare Taps Into $28 Billion Orphaned IP Market With Stake in Pilot Lite Ventures

November 28th 2016 – GE Healthcare has taken a 20% stake in global venture management company Pilot Lite Ventures (PLV), expanding its consulting business as it seeks to tap into an estimated $28 billion global market in unexploited healthcare and wellness R&D, orphaned IP and early-stage technology. GE Healthcare Partners currently offers analytics-based consulting solutions... Read more

November 15, 2016 Bio/Pharma/CRO Licensing, IP, and Legal M&A, Partnerships Product Launch

UC San Francisco and GE Healthcare Launch Deep Learning Partnership to Advance Care Globally

UC San Francisco’s Center for Digital Health Innovation and GE Healthcare today announced a partnership to develop a library of deep learning algorithms – complex problem-solving formulas – that will empower clinicians to make faster and more effective decisions about the diagnosis and management of patients with some of the most common and complex medical... Read more